HARVARD BIOSCIENCE INC

HBIO · XNAS

CIK 1123494fmd_0C8WYYPRZ8XWXMX05Y2TD8DTKBManufacturing · Laboratory Analytical InstrumentsTemplate: Standard

Coverage: Jan 01, 2009 to Sep 30, 2026, 67 periods

Income Statement · Annual · Millions · USD
Line item	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Total revenues	105	77	121	116	102	119	113	112	94	87
Cost of revenue	56	38	58	52	44	51	53	46	39	37
Gross profit	48	39	63	64	58	68	61	66	55	50
Research and development	5	6	11	11	9	11	12	12	10	9
Selling, general and administrative	41	33	46	46	43	49	50	47	44	37
Total operating expenses	51	40	62	64	58	66	68	64	61	98
Operating income	(3)	(1)	1	0	0	2	(7)	2	(6)	(49)
Interest expense	1	1	5	–	–	–	–	–	1	1
Other non-operating income (expense)	(0)	(2)	(9)	(6)	(8)	(2)	(2)	(4)	(5)	(9)
Income before taxes	(3)	(3)	(8)	(6)	(7)	(0)	(9)	(3)	(12)	(57)
Income tax expense	1	(1)	(4)	(1)	1	0	0	1	1	(1)
Net income from continuing operations	(4)	(2)	(4)	(5)	(8)	(0)	(10)	(3)	(12)	(57)
Net income	(4)	(1)	(3)	(5)	(8)	(0)	(10)	(3)	(12)	(57)